Precision Biosciences (DTIL) Debt Ratio (2021 - 2026)

Precision Biosciences (DTIL) has 6 years of Debt Ratio data on file, last reported at 0.16 in Q1 2026.

• On a quarterly basis, Debt Ratio fell 13.22% year-over-year to 0.16 in Q1 2026; TTM through Mar 2026 was 0.16, a 13.22% decrease from a year earlier, with the FY2025 full-year figure at 0.15, down 11.35% from the prior year.
• Debt Ratio for Q1 2026 stood at 0.16, up from 0.15 in the prior quarter.
• Over the last five years, Debt Ratio for DTIL reached as high as 0.24 in Q3 2025 and fell as low as 0.01 in Q1 2022.
• Historically, Debt Ratio has averaged 0.13 across 5 years, with a median of 0.14 in 2023.
• Across the five-year window, Debt Ratio surged 696.38% in 2022 and dropped 13.22% in 2026, its largest moves.
• Year by year, Debt Ratio stood at 0.09 in 2022, then jumped by 50.33% to 0.14 in 2023, then increased by 16.68% to 0.16 in 2024, then slipped by 11.35% to 0.15 in 2025, then grew by 7.39% to 0.16 in 2026.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.16 in Q1 2026, 0.15 in Q4 2025, and 0.24 in Q3 2025.